Literature DB >> 11027662

Central effects of neuromedin U in the regulation of energy homeostasis.

M Nakazato1, R Hanada, N Murakami, Y Date, M S Mondal, M Kojima, H Yoshimatsu, K Kangawa, S Matsukura.   

Abstract

Neuromedin U (NMU) is a brain-gut peptide whose peripheral activities are well-understood but whose central actions have yet to be clarified. The recent identification of two NMU receptors in rat brain has provided a springboard for further investigation into its role in the central nervous system. Intracerebroventricular administration of NMU to free-feeding rats decreased food intake and body weight. Conversely, NMU increased gross locomotor activity, body temperature, and heat production. NMU, a potent endogenous anorectic peptide, serves as a catabolic signaling molecule in the brain. Further investigation of the biochemical and physiological functions of NMU will help our better understanding of the mechanisms of energy homeostasis. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027662     DOI: 10.1006/bbrc.2000.3669

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  37 in total

1.  Neuromedin S and U.

Authors:  Colleen M Novak
Journal:  Endocrinology       Date:  2009-07       Impact factor: 4.736

2.  Gamma-Aminobutyric Acidergic Projections From the Dorsal Raphe to the Nucleus Accumbens Are Regulated by Neuromedin U.

Authors:  James M Kasper; David L McCue; Adrianna J Milton; Angelia Szwed; Catherine M Sampson; Mei Huang; Susan Carlton; Herbert Y Meltzer; Kathryn A Cunningham; Jonathan D Hommel
Journal:  Biol Psychiatry       Date:  2016-03-08       Impact factor: 13.382

3.  Discovery of potent hexapeptide agonists to human neuromedin u receptor 1 and identification of their serum metabolites.

Authors:  Kentaro Takayama; Kenji Mori; Yuko Sohma; Koji Taketa; Akihiro Taguchi; Fumika Yakushiji; Naoto Minamino; Mikiya Miyazato; Kenji Kangawa; Yoshio Hayashi
Journal:  ACS Med Chem Lett       Date:  2015-01-28       Impact factor: 4.345

4.  Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.

Authors:  T Kaisho; H Nagai; T Asakawa; N Suzuki; H Fujita; K Matsumiya; N Nishizawa; Y Kanematsu-Yamaki; K Dote; J-I Sakamoto; T Asami; S Takekawa
Journal:  Int J Obes (Lond)       Date:  2017-07-31       Impact factor: 5.095

5.  Intrathecal neuromedin U induces biphasic effects on sympathetic vasomotor tone, increases respiratory drive and attenuates sympathetic reflexes in rat.

Authors:  A A Rahman; I Z Shahid; P M Pilowsky
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 6.  Neuropeptides controlling energy balance: orexins and neuromedins.

Authors:  Joshua P Nixon; Catherine M Kotz; Colleen M Novak; Charles J Billington; Jennifer A Teske
Journal:  Handb Exp Pharmacol       Date:  2012

7.  The c-Myb target gene neuromedin U functions as a novel cofactor during the early stages of erythropoiesis.

Authors:  Julia E Gambone; Stephanie S Dusaban; Roxana Loperena; Yuji Nakata; Susan E Shetzline
Journal:  Blood       Date:  2011-03-04       Impact factor: 22.113

Review 8.  Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S.

Authors:  J D Mitchell; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2009-06-10       Impact factor: 8.739

9.  Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats.

Authors:  Jane Gartlon; Philip Szekeres; Mark Pullen; Henry M Sarau; Nambi Aiyar; Usman Shabon; David Michalovich; Klaudia Steplewski; Cathy Ellis; Nabil Elshourbagy; Mark Duxon; Tracey E Ashmeade; David C Harrison; Paul Murdock; Shelagh Wilson; Abdel Ennaceur; Alan Atkins; Christian Heidbreder; Jim J Hagan; A Jackie Hunter; Declan N C Jones
Journal:  Psychopharmacology (Berl)       Date:  2004-06-16       Impact factor: 4.530

10.  Appetite-modifying actions of pro-neuromedin U-derived peptides.

Authors:  David A Bechtold; Tina R Ivanov; Simon M Luckman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-16       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.